HCA
PRCT icon

Harbor Capital Advisors’s Procept Biorobotics PRCT Stock Holding History

Harbor Capital Advisors’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-17,381
Closed -$620K – 1370
2025
Q3 		$620K Sell
17,381
-24,515
-59% -$1.12M 0.05% 420
2025
Q2 		$2.41M Buy
+41,896
New +$2.37M 0.1% 259
2025
Q1 		– Sell
-13,995
Closed -$1.13M – 1507
2024
Q4 		$1.13M Sell
13,995
-23,519
-63% -$2.01M 0.05% 425
2024
Q3 		$3.01M Buy
+37,514
New +$2.67M 0.13% 224

Other funds holding PRCT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Harbor Capital Advisors's PRCT Position: Q4 2025 in Review

Harbor Capital Advisors sold out of Procept Biorobotics (PRCT) in Q4 2025, closing a stake of 17,381 shares — an estimated $620K sold.

Harbor Capital Advisors first reported a position in PRCT in Q3 2024 and held it in 4 quarters. The position peaked at $3.01M in Q3 2024. 263 funds tracked by Wall St. Rank hold PRCT as of Q4 2025.

  • Harbor Capital Advisors reported no remaining Procept Biorobotics position as of Q4 2025 after selling out during the quarter.
  • Harbor Capital Advisors sold 17,381 Procept Biorobotics shares in Q4 2025, an estimated $620K.
  • Harbor Capital Advisors first reported a position in Procept Biorobotics in Q3 2024 and held it in 4 quarters.
  • Harbor Capital Advisors's Procept Biorobotics position peaked at $3.01M in Q3 2024.
  • 263 funds tracked by Wall St. Rank held Procept Biorobotics as of Q4 2025.

Based on Harbor Capital Advisors's 13F filing for Q4 2025, filed 20 Jan 2026.